Allison Bratzel Score: 51
Analyst at
Piper Sandler
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+17.3%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
75%
9 W / 3 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
90%
9 W / 1 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
20%
2 W / 8 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
20%
2 W / 8 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
75%
6 W / 2 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
82%
9 W / 2 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 |
Incyte Corp.
INCY
|
BUY |
$130.00
Est. +8%
|
$120.16 | $130.80 |
Bullseye Hit (±1%)
|
$124.40
+3.5%
|
| May 08, 2026 |
enGene Holdings Inc
ENGN
|
BUY |
$4.00
Est. +133%
|
$1.72 | $1.96 |
Pending
|
$1.92
+11.6%
|
| Mar 04, 2026 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$58.00
Est. +29%
|
$44.85 | $61.75 |
Target Met
|
$57.42
+28.0%
|
| Feb 06, 2026 |
Incyte Corp.
INCY
|
BUY |
$110.00
Est. +7%
|
$102.76 | $132.58 |
Target Met
|
$124.40
+21.1%
|
| Feb 06, 2026 |
Akebia Therapeutics Inc.
AKBA
|
BUY |
$4.00
Est. +190%
|
$1.38 | $1.60 |
Pending
|
$1.03
-25.4%
|
| Nov 04, 2025 |
Incyte Corp.
INCY
|
SELL |
$102.00
Est. +0%
|
$102.35 | $89.25 (Low) |
Target Met
|
$124.40
-21.5%
|
| Sep 24, 2025 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$51.00
Est. +51%
|
$33.75 | $61.75 |
Target Met
|
$57.42
+70.1%
|
| May 16, 2025 |
Inozyme Pharma Inc
INZY
|
BUY |
$4.00
Est. +1%
|
$3.95 | $4.00 |
Bullseye Hit (±1%)
|
$4.00
+1.3%
|
| Oct 15, 2024 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$42.00
Est. +47%
|
$28.52 | $46.98 |
Target Met
|
$57.42
+101.3%
|
| May 31, 2024 |
Roivant Sciences Ltd
ROIV
|
BUY |
$20.00
Est. +92%
|
$10.39 | $13.06 |
Miss
|
$41.48
+299.2%
|
| May 23, 2024 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$28.00
Est. +150%
|
$11.18 | $46.98 |
Target Met
|
$57.42
+413.6%
|
| Apr 02, 2024 |
Q32 Bio Inc.
QTTB
|
BUY |
$45.00
Est. +150%
|
$18.00 | $53.73 |
Target Met
|
$11.69
-35.1%
|
Incyte Corp.
INCY
Aug 17, 2026
Signal & Target
BUY
$130.00
Start Price
$120.16
Best Price (1Y)
$130.80
Current Price
$124.40
Return
+3.5%
enGene Holdings Inc
ENGN
May 08, 2026
Signal & Target
BUY
$4.00
Start Price
$1.72
Best Price (1Y)
$1.96
Current Price
$1.92
Return
+11.6%
Scholar Rock Holding Corp
SRRK
Mar 04, 2026
Signal & Target
BUY
$58.00
Start Price
$44.85
Best Price (1Y)
$61.75
Current Price
$57.42
Return
+28.0%
Incyte Corp.
INCY
Feb 06, 2026
Signal & Target
BUY
$110.00
Start Price
$102.76
Best Price (1Y)
$132.58
Current Price
$124.40
Return
+21.1%
Akebia Therapeutics Inc.
AKBA
Feb 06, 2026
Signal & Target
BUY
$4.00
Start Price
$1.38
Best Price (1Y)
$1.60
Current Price
$1.03
Return
-25.4%
Incyte Corp.
INCY
Nov 04, 2025
Signal & Target
SELL
$102.00
Start Price
$102.35
Best Price (1Y)
$89.25
Current Price
$124.40
Return
-21.5%
Scholar Rock Holding Corp
SRRK
Sep 24, 2025
Signal & Target
BUY
$51.00
Start Price
$33.75
Best Price (1Y)
$61.75
Current Price
$57.42
Return
+70.1%
Inozyme Pharma Inc
INZY
May 16, 2025
Signal & Target
BUY
$4.00
Start Price
$3.95
Best Price (1Y)
$4.00
Current Price
$4.00
Return
+1.3%
Scholar Rock Holding Corp
SRRK
Oct 15, 2024
Signal & Target
BUY
$42.00
Start Price
$28.52
Best Price (1Y)
$46.98
Current Price
$57.42
Return
+101.3%
Roivant Sciences Ltd
ROIV
May 31, 2024
Signal & Target
BUY
$20.00
Start Price
$10.39
Best Price (1Y)
$13.06
Current Price
$41.48
Return
+299.2%
Scholar Rock Holding Corp
SRRK
May 23, 2024
Signal & Target
BUY
$28.00
Start Price
$11.18
Best Price (1Y)
$46.98
Current Price
$57.42
Return
+413.6%
Q32 Bio Inc.
QTTB
Apr 02, 2024
Signal & Target
BUY
$45.00
Start Price
$18.00
Best Price (1Y)
$53.73
Current Price
$11.69
Return
-35.1%